Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01920061
Title A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | ESP | CAN


No variant requirements are available.